• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Fisetin
Organic Ginger Root Extract
2,6-Diamino-4-chloropyrimidine 1-oxide
Kopexil; 2,4-Diamino pyrimidine-3-oxide
Kopyrrol
Organic Broccoli powder

Unichem Labs gets US FDA approval for Amitriptyline HCL Tablets

expresspharmaMay 21, 2021

Tag: Unichem Lab , FDA , Amitriptyline HCL Tablets

Unichem Laboratories has received ANDA approval for its Amitriptyline HCL Tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg from the United States Food and Drug Administration (USFDA) to market a generic version of ELAVIL (Amitriptyline Hydrochloride) 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg of AstraZeneca Pharmaceuticals LP.

Amitriptyline HCL Tablets are indicated for the relief of symptoms of depression.

The product will be commercialised from Unichem’s Goa Plant.

Previous:Bacteria, viruses, and fungi work as a network in causing lung infection: Study

Next:Dr Reddy’s, RDIF in discussions on production of Sputnik V for other countries

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Unichem Labs gets US FDA approval for Amitriptyline HCL Tablets | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Deoxycyline (FDA)

Deoxycyline (FDA)
Bumetanide (FDA)

Bumetanide (FDA)
Ivermectin (FDA)

Ivermectin (FDA)
Prednisolone (FDA /COS)

Prednisolone (FDA /COS)
Praziquantel (FDA)

Praziquantel (FDA)
Irinotecan Hcl trihudrate (FDA)

Irinotecan Hcl trihudrate (FDA)
Eptifibatide acetate USFDA china manufacture 99%min

Eptifibatide acetate USFDA china manufacture 99%min
9,9-Bis(4-aminophenyl) Fluorene (FDA)

9,9-Bis(4-aminophenyl) Fluorene (FDA)
Mitomycin ( FDA)

Mitomycin ( FDA)
Simvastatin (FDA)

Simvastatin (FDA)

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service